GILD · MRNA in the 13F filings
Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.
Holders over time
- GILD
- MRNA
| Quarter | GILD | MRNA |
|---|---|---|
| Q4 2020 | 27 holders, $13.4bn | 16 holders, $4.4bn |
| Q1 2021 | 24 holders, $14.5bn | 18 holders, $8.0bn |
| Q2 2021 | 18 holders, $14.9bn | 22 holders, $18.4bn |
| Q3 2021 | 20 holders, $16.4bn | 27 holders, $27.6bn |
| Q4 2021 | 20 holders, $16.8bn | 20 holders, $17.2bn |
| Q1 2022 | 28 holders, $13.2bn | 16 holders, $11.8bn |
| Q2 2022 | 26 holders, $13.6bn | 19 holders, $10.2bn |
| Q3 2022 | 24 holders, $13.3bn | 22 holders, $8.4bn |
| Q4 2022 | 32 holders, $21.1bn | 20 holders, $13.0bn |
| Q1 2023 | 27 holders, $21.8bn | 17 holders, $11.2bn |
| Q2 2023 | 24 holders, $20.7bn | 15 holders, $8.9bn |
| Q3 2023 | 24 holders, $20.0bn | 12 holders, $7.2bn |
| Q4 2023 | 22 holders, $21.5bn | 8 holders, $6.9bn |
| Q1 2024 | 30 holders, $20.3bn | 7 holders, $7.6bn |
| Q2 2024 | 28 holders, $18.5bn | 13 holders, $9.5bn |
| Q3 2024 | 29 holders, $24.2bn | 12 holders, $4.8bn |
| Q4 2024 | 28 holders, $25.9bn | 15 holders, $3.1bn |
| Q1 2025 | 33 holders, $32.0bn | 11 holders, $2.0bn |
| Q2 2025 | 27 holders, $30.9bn | 10 holders, $2.0bn |
| Q3 2025 | 23 holders, $29.4bn | 9 holders, $1.2bn |
| Q4 2025 | 25 holders, $34.3bn | 10 holders, $2.5bn |
| Q1 2026 | 25 holders, $38.5bn | 9 holders, $4.8bn |
| Q2 2026 | 26 holders, $34.2bn | 9 holders, $8.0bn |
| Q3 2026 | 31 holders, $38.6bn | 17 holders, $22.4bn |
Gilead Sciences Inc
- Holders
- 28
- Reported value
- $18.5bn
- Buyers
- 15
- Sellers
- 14
Breadth +1 among 94 comparable managers.
Moderna Inc
- Holders
- 13
- Reported value
- $9.5bn
- Buyers
- 9
- Sellers
- 4
Breadth +5 among 94 comparable managers.
Who holds both, Q2 2024
Both (9)
Capital World Investors, Fidelity (FMR LLC), Invesco Ltd, Man Group PLC, Schonfeld Strategic Advisors LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, Wellington Management Group LLP, Winton Group Ltd
Only GILD (19)
Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Bridgewater Associates LP, Capital Research Global Investors, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, Hudson Bay Capital Management LP, Janus Henderson Group Ltd, Millennium Management LLC, Point72 Asset Management LP, Renaissance Technologies LLC, Squarepoint Ops LLC, Two Sigma Advisers LP, Two Sigma Investments LP, Voloridge Investment Management LLC, Woodline Partners LP
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.